India’s CRDMO market, currently holding 2-3% of the global share, has the potential to reach $22-25 billion by 2035, says a ...

India's CRDMO sector is set to reach USD 22-25 billion by 2035, driven by cost advantages and rapid project startups, according to a BCG and IPSO report. India is emerging as a preferred outsourcing ...

The Indian Contract Research, Development, and Manufacturing Organization (CRDMO) sector is expected to touch USD 22 billion ...

A GROUNDBREAKING cancer vaccine reversed the disease in nine patients, a study has shown. All nine patients enrolled in a ...

Our Bureau, Bengaluru Tuesday, February 25, 2025, 15:15 Hrs [IST] ...

This surge is also being driven by India's cost advantages compared to Western countries, 90 per cent faster project startup ...

SHANGHAI, China I5, 2025 I YolTech Therapeutics, a clinical-stage in vivo gene editing company committed to pioneering the next generation of ...

Creative Biolabs With the enabling platforms and technologies at its disposal, Creative Biolabs is poised to address critical challenges in ...

Dr. Drew Weissman warns that a rise in anti-vaxxers could lead to deaths from preventable diseases like measles and polio, ...

Ribonucleic acid, commonly known as RNA, is involved in many biological functions, and some, including gene silencing, are utilized to cure diseases. RNA has recently gained attention as a promising ...

Bioluminescent RNA lanterns have revolutionized the way researchers track RNA activity within living organisms. In a groundbreaking study, scientists at the University of California, Irvine (UCI) ...